Blister pack with dollars instead of pills Employers are rightfully concerned about the ever-growing cost of prescription drugs, but they typically lack the data visibility and tools to do much about it. (Photo: Shutterstock)

More than ever, the push for greater transparency in prescription drug prices and lowering prescription costs for consumers and plan sponsors is gaining ground in Washington. It's encouraging to see traction at the federal policy level, given that trendlines are leading to an unsustainable cost situation for American consumers and businesses.

Continue Reading for Free

Register and gain access to:

  • Breaking benefits news and analysis, on-site and via our newsletters and custom alerts
  • Educational webcasts, white papers, and ebooks from industry thought leaders
  • Critical converage of the property casualty insurance and financial advisory markets on our other ALM sites, PropertyCasualty360 and ThinkAdvisor
NOT FOR REPRINT

© 2024 ALM Global, LLC, All Rights Reserved. Request academic re-use from www.copyright.com. All other uses, submit a request to [email protected]. For more information visit Asset & Logo Licensing.

Consumer Driven Health Care
Core and Group Health
Cost-Containment